3 Things to Know About Canopy Growth Stock After Earnings

A new focus on profitability and sustainability might stop the cash burn at Canopy Growth, so the stock can see better days.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In the aftermath of the cannabis stock bubble, we’re not left with all that much, as dashed hopes and dreams have been replaced by harsh realities. This is increasingly obvious in Canopy Growth Corp.’s (TSX:WEED) quarterly results that came out earlier this month.

Here are three things to know as we contemplate what to do next with Canopy Growth stock, a once high-flyer.

Canopy Growth is not what we expected (or hoped for)

The first thing to really wrap our heads around is the extent to which the reality of the cannabis market is different from the wildly optimistic expectations that surrounded legalization. In fact, it’s so different that this “growth” company is posting huge revenue declines. For example, Canopy posted a 28% decline in revenue in its latest quarter. Furthermore, Canadian cannabis revenue dropped 23% versus last year and 11% sequentially, as adult use has declined. Consequently, Canopy Growth stock continues to decline, which is not surprising considering these numbers. In fact, WEED stock is down 72% from its closing price at the end of 2021, and 95% from its 2018 highs.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

At first glance, this might seem shocking. Yet, consider that analysts were initially estimating that the legal cannabis market size in Canada was $7+ billion – and this was being priced into the stock. Today, it’s clear that this number was wildly inaccurate for many reasons. For example, the illicit market is thriving, with an estimated 40% market share today. The legal market has had a difficult time being competitive due to taxation and the many regulatory hurdles that exist. The regulatory environment is so punitive that the sustainability of the legal sector has actually come into question.

Switching gears – consolidating into a consumer brand company

So today, Canopy Growth’s troubles reflect these sector troubles. Not only are revenues falling fast, but losses are also piling up. In response, the company has instigated broad changes. Clearly, in order to survive, something drastic has to be done. Thus, a restructuring is under way in order to realign resources with the reality of the market.

Canopy Growth is attempting to transform into a focused consumer brand company – a premium brand-focused cannabis and consumer packaged-goods company. This means consolidating, and reducing headcount and the number of products offered. It has resulted in the divestiture of the retail operations, 800 layoffs, and ultimately, a more focused company.

Two of the brands worth mentioning are BioSteel sports drinks and Storz & Bickel (S&B) premium vape offerings. BioSteel is a fast growing energy drink that has captured more than 10% market share in Canada, and 13.8% share in Ontario. So far in 2023, BioSteel’s revenue has more than doubled. Similarly, S&B vape products are seeing strong growth. In fact, revenue growth is ramping up quickly and it was a big profit contributor in the quarter.

The promise in WEED stock lies not in market size, but profitability

The growth strategy that was followed when cannabis was first legalized in Canada has been shelved as Canopy Growth has shifted the focus to profitability and sustainability. A necessary move, as the cannabis industry pie and growth that was anticipated did not come to be.

Moving forward, Canopy must focus on margins, profitability, and cash flow. The first step is to reduce its cash burn if the company wants to live to see another day. Right now, Canopy has $800 million in cash on the balance sheet. Last quarter, the company reported a $400 million cash burn.

If they can get this under control, then we can start thinking about the potential. For example, the Canadian medical cannabis market has been growing. Last quarter, revenue increased 9%.  International revenue has also been growing, with Australian sales up 200%. Finally, the S&B vaping business is a big profit contributor with gross margins of 45%, and BioSteel has the potential to achieve gross margins of 30% to 40%.

In conclusion, Canopy Growth stock is not for the faint of heart. But it never was. At least today, we know the risks that are out there and can make a more informed decision.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has a position in Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »